Publicaciones en las que colabora con José Luis Pedraz Muñoz (32)

2004

  1. Techniques: New approaches to the delivery of biopharmaceuticals

    Trends in Pharmacological Sciences, Vol. 25, Núm. 7, pp. 382-387

2003

  1. Drug delivery in biotechnology: Present and future

    Current Opinion in Biotechnology, Vol. 14, Núm. 6, pp. 659-664

1997

  1. Influence of partial hepatectomy in rats on the activity of hepatic microsomal enzymatic systems

    European Journal of Drug Metabolism and Pharmacokinetics, Vol. 22, Núm. 1, pp. 15-23

  2. Influence of route of administration and dosage form in the pharmacokinetic and bioavailability of salbutamol

    European Journal of Drug Metabolism and Pharmacokinetics, Vol. 22, Núm. 2, pp. 145-150

1996

  1. Correlation of 'in vitro' release and 'in vivo' absorption characteristics of four salbutamol sulphate formulations

    International Journal of Pharmaceutics, Vol. 139, Núm. 1-2, pp. 45-52

1994

  1. Evaluación biofarmacéutica de comprimidos de sulfato de salbutamol: elaborados con hidroxipropilmetilcelulosa

    Industria farmacéutica: Equipos, procesos y tecnología, Núm. 2, pp. 39-45

  2. Método para la determinación de teofilina en plasma por HPLC

    Industria farmacéutica: Equipos, procesos y tecnología, Núm. 1, pp. 57-60

  3. On the employment of λ-carrageenan in a matrix system. II. λ-Carrageenan and hydroxypropylmethylcellulose mixtures

    Journal of Controlled Release, Vol. 30, Núm. 2, pp. 175-182

1993

  1. A lambda carrageenan hydrophilic matrix for constant release of salbutamol sulphate

    Proceedings of the Controlled Release Society

  2. Métodos de estudio del metabolismo de medicamentos

    Industria farmacéutica: Equipos, procesos y tecnología, Núm. 2, pp. 39-50

  3. On the employment of λ-carrageenan in a matrix system. I. Sensitivity to dissolution medium and comparison with Na carboxymethylcellulose and xanthan gum

    Journal of Controlled Release, Vol. 26, Núm. 2, pp. 119-127

1991

  1. Biotransformation kinetic of binifibrate and identification of its metabolites

    Bollettino Chimico Farmaceutico, Vol. 130, Núm. 5, pp. 172-177

  2. Influence of ecxipient in the release of ketamine from suppositories

    Bollettino Chimico Farmaceutico, Vol. 130, Núm. 2, pp. 52-54

  3. Pharmacokinetics and distribution of ketamine after extradural administration to dogs

    British Journal of Anaesthesia, Vol. 67, Núm. 3, pp. 310-316

  4. Pharmacokinetics of cefazoline and dibenzylamine administered in a sustained drug delivery system to healthy volunteers

    International Journal of Pharmaceutics, Vol. 67, Núm. 3, pp. 259-264

  5. VALIDEZ DE LA INVESTIGACION PRECLINICA EN EL DESARROLLO DE NUEVOS ANTIBIOTICOS. ASPECTOS FARMACOCINETICOS

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 9, Núm. 6, pp. 361-369

1989

  1. Determination of low concentrations of dibenzylamine in human plasma and urine by gas chromatography with a nitrogen-phosphorus detector

    Journal of Chromatography B: Biomedical Sciences and Applications, Vol. 490, Núm. C, pp. 206-212

  2. Pharmacokinetics of rectal ketamine in children

    British Journal of Anaesthesia, Vol. 63, Núm. 6, pp. 671-674

1988

  1. Allometric study of ketamine pharmacokinetics

    Revista de Farmacologia Clinica y Experimental, Vol. 5, Núm. 3, pp. 331-336

  2. Bioequivalence study of two oral formulations of paracetamol

    International Journal of Clinical Pharmacology Therapy and Toxicology, Vol. 26, Núm. 5, pp. 232-236